 | • レポートコード：TPM-NV209 • 出版社/出版日：Transparency Market Research / 2019年10月28日 • レポート形態：英文、PDF、200ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、肛門灌漑システムの世界市場について調べ、肛門灌漑システムの世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別（ミニデバイス、コーンデバイス、バルーンカテーテルデバイス、およびベッドシステム）分析、患者別（子供、大人）分析、エンドユーザー別（病院、診療所、外来手術センター、在宅ケアセッティング、およびリハビリテーションセンター）分析、関連企業情報などをまとめました。 ・肛門灌漑システムの市場概要 ・肛門灌漑システムの市場動向 ・肛門灌漑システムの世界市場規模・予測 ・肛門灌漑システム市場：製品別（ミニデバイス、コーンデバイス、バルーンカテーテルデバイス、およびベッドシステム） ・肛門灌漑システム市場：患者別（子供、大人） ・肛門灌漑システム市場：患者別（子供、大人） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
Faecal incontinence and chronic constipation is a health issue prevalent in many adults and children. This is why manufacturers are innovating on novel anal irrigation systems that help individuals and healthcare providers prevent chronic constipation and support efficient bowel management.
Manufacturers are creating awareness about trans-anal irrigation (TAI) therapy to treat chronic functional constipation in adults. As such, trans-anal irrigation systems are being widely used to treat bowel dysfunction. Positive outcomes in patients are triggering the demand for efficacious anal irrigation systems that are as good as pharmacological therapies.
Trans-anal irrigation therapy is emerging as a safe treatment option for patients with functional constipation and other chronic refractory conditions. Revenue from anal irrigation therapy in Europe accounted for ~US$ 115 million in 2018; the highest amongst all regions. This is why healthcare providers are making widespread use of trans-anal irrigation systems in the U.K. As such, manufacturers are increasing their production capacities of low-volume systems, since they serve as a cost-effective option as compared to high-volume systems.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Anal Irrigation Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anal Irrigation Systems Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Key Vendor and Distributor Analysis
5.2. Key Mergers & Acquisitions
5.3. Regulatory Scenario, by Region/globally
5.4. Top 3 players operating in the market space
6. Global Anal Irrigation Systems Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Mini Devices
6.3.2. Cone Devices
6.3.3. Balloon Catheter Devices
6.3.4. Bed Systems
6.4. Market Attractiveness, by Product
7. Global Anal Irrigation Systems Market Analysis and Forecast, by Patient
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Patient, 2017–2027
7.3.1. Children
7.3.2. Adults
7.4. Market Attractiveness, by Patient
8. Global Anal Irrigation Systems Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Clinics
8.3.4. Home Care Settings
8.3.5. Rehabilitation Centers
8.4. Market Attractiveness, by End-user
9. Global Anal Irrigation Systems Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Anal Irrigation Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2027
10.2.1. Mini Devices
10.2.2. Cone Devices
10.2.3. Balloon Catheter Devices
10.2.4. Bed Systems
10.3. Market Value Forecast, by Patient, 2017–2027
10.3.1. Children
10.3.2. Adults
10.4. Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Clinics
10.4.4. Home Care Settings
10.4.5. Rehabilitation Centers
10.5. Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Patient
10.6.3. By End-user
10.6.4. By Country
11. Europe Anal Irrigation Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2027
11.2.1. Mini Devices
11.2.2. Cone Devices
11.2.3. Balloon Catheter Devices
11.2.4. Bed Systems
11.3. Market Value Forecast, by Patient, 2017–2027
11.3.1. Children
11.3.2. Adults
11.4. Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Clinics
11.4.4. Home Care Settings
11.4.5. Rehabilitation Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Netherlands
11.5.7. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Patient
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Anal Irrigation Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2027
12.2.1. Mini Devices
12.2.2. Cone Devices
12.2.3. Balloon Catheter Devices
12.2.4. Bed Systems
12.3. Market Value Forecast, by Patient, 2017–2027
12.3.1. Children
12.3.2. Adults
12.4. Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Clinics
12.4.4. Home Care Settings
12.4.5. Rehabilitation Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Patient
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Anal Irrigation Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2027
13.2.1. Mini Devices
13.2.2. Cone Devices
13.2.3. Balloon Catheter Devices
13.2.4. Bed Systems
13.3. Market Value Forecast, by Patient, 2017–2027
13.3.1. Children
13.3.2. Adults
13.4. Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Clinics
13.4.4. Home Care Settings
13.4.5. Rehabilitation Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Patient
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Anal Irrigation Systems Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2027
14.2.1. Mini Devices
14.2.2. Cone Devices
14.2.3. Balloon Catheter Devices
14.2.4. Bed Systems
14.3. Market Value Forecast, by Patient, 2017–2027
14.3.1. Children
14.3.2. Adults
14.4. Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Clinics
14.4.4. Home Care Settings
14.4.5. Rehabilitation Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Patient
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share/Position Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Coloplast A/S
15.3.1.1. Overview (HQ, Employee Strength, Business Segments)
15.3.1.2. Financials
15.3.1.3. Recent Developments
15.3.1.4. Strategy
15.3.2. B. Braun Melsungen AG
15.3.2.1. Overview (HQ, Employee Strength, Business Segments)
15.3.2.2. Financials
15.3.2.3. Recent Developments
15.3.2.4. Strategy
15.3.3. ConvaTec Group plc
15.3.3.1. Overview (HQ, Employee Strength, Business Segments)
15.3.3.2. Financials
15.3.3.3. Recent Developments
15.3.3.4. Strategy
15.3.4. Becton, Dickinson and Company (BD)
15.3.4.1. Overview (HQ, Employee Strength, Business Segments)
15.3.4.2. Financials
15.3.4.3. Recent Developments
15.3.4.4. Strategy
15.3.5. Aquaflush Medical Limited
15.3.5.1. Overview (HQ, Employee Strength, Business Segments)
15.3.5.2. Financials
15.3.5.3. Recent Developments
15.3.5.4. Strategy
15.3.6. MBH-International A/S
15.3.6.1. Overview (HQ, Employee Strength, Business Segments)
15.3.6.2. Financials
15.3.6.3. Recent Developments
15.3.6.4. Strategy
15.3.7. Wellspect HealthCare (a Dentsply Sirona Company)
15.3.7.1. Overview (HQ, Employee Strength, Business Segments)
15.3.7.2. Financials
15.3.7.3. Recent Developments
15.3.7.4. Strategy
15.3.8. Consure Medical
15.3.8.1. Overview (HQ, Employee Strength, Business Segments)
15.3.8.2. Financials
15.3.8.3. Recent Developments
15.3.8.4. Strategy
15.3.9. HTKD Medical
15.3.9.1. Overview (HQ, Employee Strength, Business Segments)
15.3.9.2. Financials
15.3.9.3. Recent Developments
15.3.9.4. Strategy
15.3.10. ProSys International Ltd.
15.3.10.1. Overview (HQ, Employee Strength, Business Segments)
15.3.10.2. Financials
15.3.10.3. Recent Developments
15.3.10.4. Strategy